Abstract
The transverse relaxation time, T2, of native cartilage is used to quantify cartilage degradation. T2 is frequently measured after contrast administration, assuming that the impact of gadolinium-based contrast agents on cartilage T2 is negligible. To verify this assumption the depth-dependent variation of T2 in the presence of gadopentetate dimeglumine, gadobenate dimeglumine and gadoteridol was investigated. Furthermore, the r2/r1 relaxivity ratios were quantified in different cartilage layers to demonstrate differences between T2 and T1 relaxation effects. Transverse high-spatial-resolution T1- and T2-maps were simultaneously acquired on a 1.5 T MR scanner before and after contrast administration in nine bovine patellae using a turbo-mixed sequence. The r2/r1 ratios were calculated for each contrast agent in cartilage. Profiles of T1, T2 and r2/r1 across cartilage thickness were generated in the absence and presence of contrast agent. The mean values in different cartilage layers were compared for global variance using the Kruskal–Wallis test and pairwise using the Mann–Whitney U-test. T2 of unenhanced cartilage was 98 ± 5 ms at 1 mm and 65 ± 4 ms at 3 mm depth. Eleven hours after contrast administration significant differences (p < 0.001) were measurable for all three contrast agents. T2 values were 58 ± 2 and 62 ± 3 ms for gadopentetate dimeglumine, 46 ± 2 and 57 ± 2 ms for gadobenate dimeglumine, and 38 ± 2 and 42 ± 2 ms for gadoteridol at 1 and 3 mm depths, respectively. The r2/r1 relaxivity ratios across cartilage thickness were close to 1.0 (range 0.9–1.3). At 1.5 T, T2 decreased significantly in the presence of contrast agents, more pronounced in superficial than in deep cartilage. The change in T2 relaxation rate was similar to the change in T1. Cartilage T2 measurements after contrast administration will lead to systematic errors in the quantification of cartilage degradation. Copyright © 2010 John Wiley & Sons, Ltd.

This publication has 32 references indexed in Scilit: